Clinical Characteristics and Outcomes of Severe and Critical Patients With 2019 Novel Coronavirus Disease (COVID-19) in Wenzhou: A Retrospective Study
Author:
Funder
National Natural Science Foundation of China
Publisher
Frontiers Media SA
Subject
General Medicine
Reference19 articles.
1. Director-General's Remarks at the Media Briefing on 2019-nCoV on 11 February 20202020
2. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series;Xu;BMJ,2020
3. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2;Xu;J Infect,2020
4. Clinical characteristics of Coronavirus disease 2019 in China;Guan;N Engl J Med,2020
5. Coronavirus disease 2019 (COVID-19): A critical care perspective beyond China;Rello;Anaesth Crit Care Pain Med,2020
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mild‐to‐moderate COVID‐19 does not predispose to the development of autoimmune rheumatic diseases or autoimmune‐based thrombosis;Scandinavian Journal of Immunology;2023-07-26
2. Prevention, diagnostic evaluation, management and prognostic implications of liver disease in critically ill patients with COVID-19;World Journal of Clinical Cases;2023-01-26
3. Health-Related Quality of Life of Moroccan COVID-19 Survivors: A Case-Control Study;International Journal of Environmental Research and Public Health;2022-07-20
4. Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome;Vaccines;2022-02-18
5. Anti-SARS-CoV-2 vaccination does not induce the formation of autoantibodies but provides humoral immunity following heterologous and homologous vaccination regimens: Results from a clinical and prospective study within professionals of a German University Hospital;2021-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3